Literature DB >> 3267330

Intraventricular haematoma: management of comatose patients with valve regulated external ventricular drainage.

K H Chan1, K S Mann.   

Abstract

Over a 2-year period, 22 consecutive comatose patients (Glasgow Coma Score of less than or equal to 8) with intraventricular haematomas were managed with prolonged external ventricular drainage via an external one-way valve regulated system. The mean duration of drainage was 12 days. The overall mortality was 23%. According to the Glasgow Outcome Scale, 36% had severe to moderate disability and 41% made good recovery. Mortality and morbidity were closely related to the type of intraventricular haematoma and patients' preoperative clinical state. Drainage related complications: infection, and ventricular catheter blockage requiring revision, were not observed as a result of this technique. Of the survivors, nine eventually required ventriculoperitoneal shunts. Sump and valve regulated external ventricular drainage is, therefore, a useful procedure in the management of patients with extensive intraventricular haematoma.

Entities:  

Mesh:

Year:  1988        PMID: 3267330     DOI: 10.3109/02688698809029600

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage.

Authors:  V Rohde; C Schaller; W E Hassler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

2.  Long-tunneled versus short-tunneled external ventricular drainage: Prospective experience from a developing country.

Authors:  Muhammad Zubair Tahir; Zain A Sobani; Muhammed Murtaza; Syed Ather Enam
Journal:  Asian J Neurosurg       Date:  2016 Apr-Jun

3.  Spontaneous primary intraventricular hemorrhage: clinical features and early outcome.

Authors:  Adrià Arboix; Luis García-Eroles; Adela Vicens; Montserrat Oliveres; Joan Massons
Journal:  ISRN Neurol       Date:  2012-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.